Needham Maintains Buy on Hinge Health, Raises Price Target to $115
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice Target
Needham analyst Ryan MacDonald maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $97 to $115.
Needham analyst Ryan MacDonald maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $97 to $115.